Vimarsana
Biggest News Aggregation in the World

Page 12 - Advanced Solid Tumors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advanced Solid Tumors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advanced Solid Tumors Today - Breaking & Trending Today

Tyra Biosciences Initiates SURF301 Phase 1/2 Clinical Study and Doses First Patient with TYRA-300 - Vimarsana News

Tyra Biosciences Initiates SURF301 Phase 1/2 Clinical Study and Doses First Patient with TYRA-300

/PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance...

Tyra Biosciences Initiates SURF301 Phase 1/2 Clinical Study and Doses First Patient with TYRA-300 - Vimarsana News

Tyra Biosciences Initiates SURF301 Phase 1/2 Clinical Study and Doses First Patient with TYRA-300

-TYRA-300 is the first oral, FGFR3-selective agent to be evaluated in the clinic- -Conference call and webcast today, Nov. 29th, at 9:00 am ET- CARLSBAD, Calif., Nov. 29, 2022 /PRNewswire/ -- Tyra...

Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of - Vimarsana News

Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of

Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma

Exelixis Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

Exelixis Announces Third Quarter 2022 Financial Results and Provides Corporate Update

– Total Revenues of $411.7 million, Cabozantinib Franchise Revenues of $366.5 million – – GAAP Diluted EPS of $0.23, Non-GAAP Diluted EPS of $0.31 – – Conference Call... | November 1, 2022

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Faron Announces Poster Presentation at SITC - Vimarsana News

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Faron Announces Poster Presentation at SITC

Investegate announcements from Faron Pharma. Oy, Faron Announces Poster Presentation at SITC